Caption Management »

Silence Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.1M 460k 10.98

More positions owned by Caption Management

Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Western Digital (WDC)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Carvana Cl A Call Option (CVNA)
Warner Bros Discovery Com Ser A Call Option (WBD)
United Therapeutics Corporation (UTHR)
Blue Owl Capital Com Cl A (OWL)
Tesla Motors (TSLA)
Take-Two Interactive Software (TTWO)
Cg Oncology (CGON)
Electronic Arts (EA)
Spdr Series Trust St Str Sp Regbnk (KRE)

View all positions for Caption Management

Top funds holding Silence Therapeutics

Siren
TCG Crossover Management
Redmile Group
Nantahala Capital Management
Citadel Advisors
Polygon Management
Nextech Invest
Millennium Management
Ikarian Capital
Soleus Capital Management
Balyasny Asset Management
5AM Venture Management
Caption Management
Dr. Jeffrey R. Jay, M.D.
Jane Street

View all funds holding Silence Therapeutics